SCHEMBL822129

SCHEMBL822129

CC(=O)OCC(O)COC(=O)CO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
DUSP3 P51452 1/20 0.42
ALDH1A1 P00352 3/20 0.40
MAPT P10636 3/20 0.40
USP2 O75604 2/20 0.40
CYP3A4 P08684 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.37
LPAR6 P43657 1/20 0.37
LPAR1 Q92633 1/20 0.37
LPAR4 Q99677 1/20 0.37
LPAR5 Q9H1C0 1/20 0.37
LPAR2 Q9HBW0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414406 0.89 KDM4E (0.44) MEN1KMT2ALMNAKDM4EDUSP3
SCHEMBL304203 0.86 TDP1 (0.54) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL10799810 0.84 MEN1 (0.47) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL6929609 0.83 TDP1 (0.44) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL14700392 0.83 TDP1 (0.44) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL16167891 0.82 MEN1 (0.50) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL20781443 0.80 GAA (0.38) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL299289 0.79 LMNA (0.55) MEN1KMT2ALMNAKDM4EDUSP3
SCHEMBL6131221 0.79 TDP1 (0.48) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL33457 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 TDP1 2133/4885MEN1 1922/4885KMT2A 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.